{
    "SPADE_N_03152": {
        "Clinical Information": [],
        "Patent Information": [
            {
                "Patent No": "WO 2020/144166 A1",
                "Patent Link": "http://www.lens.org/lens/patent/WO_2020_144166_A1",
                "Patent Type": "Patent Application",
                "Publication Date": "2020-7-16",
                "Family Info": "/",
                "Patent Title": "Defensin Fragments For Use In Therapy Or Prophylaxis",
                "Abstract": "The present invention relates to new peptides derived from HD-5 or HNP-4 having antimicrobial activity for use in modulating the microbiome of intestines, the lungs, the skin, the mouth, the eye, the ear, the vagina or other bodily surfaces and/or for use as an antimicrobial agent in a human or other mammals, as well as to medicaments containing these peptides."
            }
        ],
        "Sequence Information": {
            "SPADE ID": "SPADE_N_03152",
            "Peptide Name": "Human defensin-5 (HD-5; Defensin, alpha 5; Human, mammals, animals)",
            "Source": "Homo sapiens (Human)",
            "Family": "Belongs to the alpha-defensin family",
            "Gene": "DEFA5",
            "Sequence": "ATCYCRTGRCATRESLSGVCEISGRLYRLCCR",
            "Sequence Length": 32,
            "UniProt Entry": [
                "http://www.uniprot.org/uniprot/Q01523",
                "http://www.uniprot.org/uniprot/A0JDY6",
                "http://www.uniprot.org/uniprot/Q3KNV2"
            ],
            "Protein Existence": "Protein level",
            "Biological Activity": [
                "Antimicrobial",
                "Antibacterial",
                "Anti-Gram+",
                "Anti-Gram-",
                "Antifungal",
                "Antiviral(SARS-CoV-2)"
            ],
            "Target Organism": "[Ref.34206990]Virus:SARS-CoV-2:inhibition of infection in HEK293T-hACE2 cells(60% inhibition at 12.5 μg/mL (3.45 μM));SARS-CoV-2 variant P.1:inhibition of infection in HeLa-hACE2 cells(72% inbibition at 50 μg/mL);SARS-CoV-2 variant B.1.1.7:inhibition of infection in HeLa-hACE2 cells(32% inbibition at 50 μg/mL).Gram-negative bacteria:Escherichia coli ATCC 8739 (vLD50=2.5±0.3 µg/ml), E. coli ATCC 25922 (vLD50=2.1±0.9 µg/ml), Enterobacter aerogenes ATCC 13048 (vLD50=5.5±0.5 µg/ml);Gram-positive bacteria:Staphylococcus aureus ATCC 25923 (vLD50=6.3±0.5 µg/ml), S. aureus ATCC 29213 (vLD50=3.2±0.3 µg/ml), Bacillus cereus ATCC 10876 (vLD50<0.31 µg/ml).(Ref.2)NOTE:vLD50, virtual lethal doses (vLDs), equivalent to conventional 50% lethal doses (LD50s).",
            "Hemolytic Activity": "[Ref.26206286] It has 0% hemolysis at 100μM against human red blood cells.",
            "Cytotoxicity": "[Ref.34206990]No cytotoxicity on HEK293T cells up to 50 μg/mL.",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Cyclic",
            "N-terminal Modification": "Free",
            "C-terminal Modification": "Free",
            "Stereochemistry": "L",
            "Structure Description": "The L- and D-forms of HD-5 are equally active than E.coli but not S. aureus (Wei G et al 2009 JBC 284: 29180-92).",
            "Formula": "C144H244N50O45S6",
            "Mass": 3588.18,
            "PI": 8.96,
            "Net Charge": 4,
            "Hydrophobicity": -0.11,
            "Half Life": "Mammalian:4.4 hourYeast:>20 hourE.coli:>10 hour",
            "Function": "Antimicrobial activity against Gram-negative and Gram-positive bacteria. Defensins are thought to kill microbes by permeabilizing their plasma membrane. All DEFA5 peptides exert antimicrobial activities, but their potency is affected by peptide processing.",
            "Tissue specificity": "Paneth cells of the small intestine (at protein level).",
            "PTM": "Contains three disulfide bonds.",
            "Literature": [
                {
                    "Title": "Human Defensins Inhibit SARS-CoV-2 Infection by Blocking Viral Entry.",
                    "Pubmed ID": "34206990",
                    "Reference": "Viruses. 2021 Jun 26;13(7)1246.",
                    "Author": "Xu C, Wang A, Marin M, Honnen W, Ramasamy S, Porter E, Subbian S, Pinter A, Melikyan GB, Lu W, Chang TL.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=34206990"
                },
                {
                    "Title": "Paneth cell trypsin is the processing enzyme for human defensin-5.",
                    "Pubmed ID": "12021776",
                    "Reference": "Nat Immunol. 2002 Jun;3(6)583-590.",
                    "Author": "Ghosh D, Porter E, Shen B, Lee SK, Wilk D, Drazba J, Yadav SP, Crabb JW, Ganz T, Bevins CL.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=12021776"
                },
                {
                    "Title": "Antibacterial activity and specificity of the six human {alpha}-defensins.",
                    "Pubmed ID": "15616305",
                    "Reference": "Antimicrob Agents Chemother. 2005 Jan;49(1)269-275.",
                    "Author": "Ericksen B, Wu Z, Lu W, Lehrer RI.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=15616305"
                },
                {
                    "Title": "Antimicrobial activity of human  -defensin 5 and its linear analogs N-terminal fatty acylation results in enhanced antimicrobial activity of the linear analogs",
                    "Pubmed ID": "26206286",
                    "Reference": "Peptides. 2015 Sep;71128-40. doi 10.1016/j.peptides.2015.07.009. Epub 2015 Jul 20.",
                    "Author": "Basil Mathew Ramakrishnan Nagaraj",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=26206286"
                }
            ],
            "Frequent Amino Acids": "CRG",
            "Absent Amino Acids": "DFHKMNOPQUW",
            "Basic Residues": 6,
            "Acidic Residues": 2,
            "Hydrophobic Residues": 9,
            "Polar Residues": 23,
            "Positive Residues": 6,
            "Negative Residues": 2,
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_05889",
                    "Similarity": 1.0,
                    "Sequence": "ATCYCRTGRCATRESLSGVCEISGRLYRL"
                },
                {
                    "SPADE_ID": "SPADE_N_05891",
                    "Similarity": 1.0,
                    "Sequence": "ATCYCRTGRCATRESLSGVCEISGRLYR"
                },
                {
                    "SPADE_ID": "SPADE_N_05892",
                    "Similarity": 1.0,
                    "Sequence": "ATCYCRTGRCATRESLSGVCEISGRLY"
                }
            ]
        }
    }
}